 |
 |
|
All orders receive free 2-3 day Priority Mail service. UPS and Fedex also available at checkout. |
Attention:
International Customers receive free shipping on all orders over $140.00 to the following countries:
Australia
Canada
United Kingdom
Netherlands
Singapore
|
|
 |
 |  |
|
Idiopathic Pulmonary Fibrosis
Definition
Idiopathic pulmonary fibrosis (IPF) is a chronic disease that causes inflammation (swelling and irritation) and fibrosis (scarring) of tissue in the lungs. The cause of IPF is unknown, and currently there is no FDA approved treatment. It usually occurs in people between ages 50-70. Pulmonary Fibrosis literally means lung (pulmonary) scarring (fibrosis). The lung scarring occurs in the tissue of the lung called the interstitium, which supports the structures of the lung (air sacs/alveoli). There are an estimated 130-200 related diseases called Interstitial Lung Disease that are similar in characteristics and can result in scarring. Pulmonary Fibrosis causes the lung tissue to thicken and become stiff. Scarring inhibits oxygen from entering the blood stream.
Causes
The word "idiopathic" in the name of this disease means the cause is not known. Researchers think that IPF involves an exaggerated and uncontrolled inflammatory response that produces the fibrous scar tissue. What starts the injury and abnormal healing is not known. Over time, scarring surrounds the thin-walled air sacs in the lungs (alveoli). This makes the tissue thicker and stiffer. As a result, breathing becomes difficult, and the lungs gradually lose their ability to provide oxygen to the rest of the body.
Risk Factors
A risk factor is something that increases your chance of getting a disease or condition. Although the cause of IPF is not known, the factors below may increase the risk of getting it:
- Cigarette smoking
- Occupational exposure to metal or wood dust
- Viral infection
- Other family members with IPF |
Treatment
IPF worsens over time, and there is no known cure. The goal of treatment is to improve symptoms and slow the disease process by reducing inflammation and scarring. The tissue that is already scarred cannot be returned to normal.
Medication is the main form of treatment, although it does not work for some people, and none of these medications have been designed strictly for pulmonary fibrosis. A common combination is prednisone to reduce inflammation along with cytoxan to reduce the body's immune response. Some people may need to receive oxygen to help them breathe. Maintaining a healthy lifestyle in terms of diet, exercise, rest, and not smoking may also help slow the disease. Lung transplantation may be considered for people with advanced IPF who do not respond to other treatment.
 |
Neprinol AFD , now available without a doctor's prescription, offers excellent hope for those suffering from Pulmonary Fibrosis. Neprinol is a highly potent systemic enzyme blend. Enzymes, such as those found in Neprinol AFD, have been found to dissolve scar tissue, and like prescription drugs, work as an anti-inflammatory breaking down scar tissue and restoring health to the area. Unlike prescription medication, Neprinol has no side-effects, and can be taken for prolonged amounts of time. If we replace the lost enzymes, we can control and reduce the amount of scar tissue and fibrosis our bodies have. As physicians in the US are now discovering, even old scar tissue can be "eaten away" from surgical wounds, pulmonary fibrosis, and kidney fibrosis even colloid years after their formation.
NEPRINOL® is composed of Pharmaceutical-grade ingredients, provided exclusively through licensed healthcare practitioners and supplementation outlet stores. NEPRINOL® is 100% natural and contains no animal derivatives it is available now without a prescription.
Warning:
Neprinol is safe to use with all supplements and all prescription medication except blood-thinners and anticoagulants such as Coumadin, Plavix and Heparin. Please consult your doctor before taking Neprinol if you are currently taking such a product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. |
|
|
|  |
|
|
 |
 |
 |
| | |
Site Mailing List
Sign Guest Book
View Guest Book
Your Gateway to Well-Being-Neprinol
Fibromedica Health Solutions, Inc.
Email: sales@fibromedica.com
Many of the statements in this website have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
| |
|
|
|
 |
|
A new enzyme said to rival pharmaceutical agents has been discovered and shows great potential in providing support for hypercoagulative states. A natural enzyme, Nattokinase, is derived from fermented soy and the bacteria Bacillus natto. Already, backed by research, this enzyme has showed great promise in areas such as cardiovascular disease, angina, venous stasis, thrombosis, emboli, stroke, atherosclerosis, fibromyalgia/chronic fatigue, claudication, hemorrhoids, varicose veins, retinal pathology, soft tissue rheumatisms, muscle spasm, poor healing, chronic inflammation and pain, peripheral vascular disease, hypertension, tissue oxygen deprivation, infertility, and other gynecological conditions (e.g. endometriosis, uterine fibroids).
|
 |
|
Fibromedica Health Solutions
Authorized Neprinol Distributor
For Promotions: promotions@fibromedica.com
Open Daily To Serve You
For Questions Call or Email:
Toll Free:
(888) 436-0966
24 Hr. Service:
(800) 407-2895 (Se Habla Espanol)
Email:
sales@fibromedica.com
|
|
|
 |
|
|
|
